Navigation Links
InterMune Announces Receipt of Fast Track Designation for Pirfenidone From FDA
Date:5/19/2008

- Conference call scheduled to discuss Shionogi Phase 3 results on

pirfenidone -

BRISBANE, Calif., May 19 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN) today announced that its program for the development of pirfenidone for the treatment of idiopathic pulmonary fibrosis (IPF) has received "Fast Track" designation from the U.S. Food and Drug Administration (FDA). Fast Track is a designation that the FDA reserves for a drug intended to treat a serious or life threatening condition and one that demonstrates the potential to address an unmet medical need for the condition. The FDA takes appropriate actions to facilitate the development and expedite the review of the approval applications for fast track products.

Dan Welch, Chairman and Chief Executive Officer of InterMune, said, "There are no approved medicines to treat patients who suffer from IPF, a uniformly fatal disease characterized by scarring and inflammation of the lungs. The FDA's action in granting fast track designation is an indication of pirfenidone's potential to address this serious, unmet medical need. We look forward to reporting top-line results of our Phase 3 CAPACITY program of pirfenidone in IPF, in January of 2009."

Webcast and Conference Call on May 20, 5:00 p.m. EDT

InterMune additionally announced that it will conduct a live webcast and conference call on May 20, 2008 at 5:00 p.m. EDT to discuss its Phase 3 CAPACITY program in the context of data that will be presented by Shionogi & Co., Ltd. regarding its Phase 3 trial of pirfenidone in Japan. The Shionogi Phase 3 results are scheduled to be reported in an oral presentation at the meeting of the American Thoracic Society in Toronto at 2:15 p.m.
'/>"/>

SOURCE InterMune, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. InterMune Announces Progress on Pirfenidone in IPF
2. InterMune Provides Additional Information on ITMN-191 (R7227) MAD Study Results
3. InterMune Announces Top-Line Results of Phase 1b Trial of ITMN-191 (R7227) and Provides Program Update
4. InterMune Announces Start of Phase 1b Trial of ITMN-191
5. InterMune Announces Approval of Clinical Trial Authorization for Phase 1b Trial of ITMN-191
6. Ipsogen Announces Three Studies at the American Society of Clinical Oncology (ASCO) Meeting Extending the Utility of the Genomic Grade Index for Predicting Response to Chemotherapy in Breast Cancer
7. TAP Pharmaceutical Products Inc. Announces Phase 3 TAK-390MR Data Demonstrating Higher Overall Healing Versus Lansoprazole in Patients with Erosive Esophagitis
8. Pulmo BioTech Announces Details of the Methodology for its Phase I Human Trials
9. GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab)
10. ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study
11. Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Mass., Dec. 16 Boston Scientific Corporation (NYSE: ... Board of Directors has elected Nelda Connors as a ... of the Electrical and Metal Products division of Tyco ... Eaton Corporation, holding several positions in operations and general ... in a number of executive and management capacities with ...
(Date:12/16/2009)... Siemens Healthcare today announced a series ... to help healthcare providers pursue meaningful ... the HITECH provision of the American Recovery ... zero-percent interest terms for qualified customers, the ... associated with their technology investment while meeting ...
(Date:12/16/2009)... 16 BioSpecifics Technologies Corp. (Nasdaq: ... class collagenase-based products, today announced top-line efficacy and ... of XIAFLEX(TM) for the treatment of Peyronie,s disease. ... inelastic collagen on the shaft of the penis, ... intercourse difficult or impossible in advanced cases. The ...
Breaking Medicine Technology:Boston Scientific Announces Election of Nelda Connors to Its Board of Directors 2Boston Scientific Announces Election of Nelda Connors to Its Board of Directors 3Siemens Unveils Flexible Financing Solutions to Help Providers Achieve Meaningful Use 2Siemens Unveils Flexible Financing Solutions to Help Providers Achieve Meaningful Use 3Siemens Unveils Flexible Financing Solutions to Help Providers Achieve Meaningful Use 4BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronie's Disease 2BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronie's Disease 3BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronie's Disease 4CBS and OMD Partner to Provide the Agency With Access to the Networks Television City Research Facility in Las Vegas 10669 1CBS and OMD Partner to Provide the Agency With Access to the Networks Television City Research Facility in Las Vegas 10669 2CBS and OMD Partner to Provide the Agency With Access to the Networks Television City Research Facility in Las Vegas 10669 3CBS and OMD Partner to Provide the Agency With Access to the Networks Television City Research Facility in Las Vegas 10669 4Wet ethanol production process yields more ethanol and more co products 10667 1Wet ethanol production process yields more ethanol and more co products 10667 2Abt Associates Expands Emergency Management Support Services To the Federal Government and Washington Metropolitan Area Transit Authority 60993 1Abt Associates Expands Emergency Management Support Services To the Federal Government and Washington Metropolitan Area Transit Authority 60993 2
... DuoCort AB,today announced that results of the Phase ... dual release hydrocortisone tablets for adrenal insufficiency,will be ... on,April 30 in Budapest. The trial evaluated the ... healthy,volunteers., The Phase I study showed that both ...
... BioDelivery,Sciences International, Inc. (Nasdaq: BDSI) announced today,statistically ... with breakthrough pain in its pivotal Phase ... results are based on,achievement of the primary ... Intensity Difference (SPID), compared to placebo., The ...
Other Medicine Technology:DuoCort AB: DuoCort announces Phase I Data Presentation at the,European Congress of Endocrinology 2BDSI Announces Positive Phase III Clinical Trial Results for BEMA,Fentanyl 2BDSI Announces Positive Phase III Clinical Trial Results for BEMA,Fentanyl 3BDSI Announces Positive Phase III Clinical Trial Results for BEMA,Fentanyl 4BDSI Announces Positive Phase III Clinical Trial Results for BEMA,Fentanyl 5BDSI Announces Positive Phase III Clinical Trial Results for BEMA,Fentanyl 6
(Date:12/16/2009)... Mich., Dec. 16 The most widely used human ... that raises social justice questions that must be addressed ... stem cell advances, according to a University of Michigan ... its kind, the U-M team analyzed 47 embryonic stem ... by stem cell researchers. The scientists determined the genetic ...
(Date:12/16/2009)... reducing inflammation in the lungs , , WEDNESDAY, Dec. 16 ... role in inflammation seems to protect the lungs of ... , Researchers also found that adult smokers with this ... of developing chronic obstructive pulmonary disease (COPD), a progressive ... seems to be protective of the lungs in both ...
(Date:12/16/2009)... New Immune-boosting, Newborn-Safe Skin Care Products from Episencial Offers Planet-Friendly ... Now Available , ... Los Angeles, ... green values now have an authentic, affordable choice in all ... launches its eponymous product line for young children featuring ...
(Date:12/16/2009)... Stress Reduction Therapy or NSRTSM is found very effective in ... as allergies, asthma, migraines, chronic fatigue and a wide array ... country are using this holistic therapy including over 50 branded ... ... Minneapolis, MN (Vocus) December 14, 2009 -- BioVeda Health ...
(Date:12/16/2009)... Shoppers like knowing if their salad ... But grocers have found it burdensome to implement ... requiring them to provide the information at point ... easyCOOLnow.com for easily making grocery and produce ... that require retailers of unprocessed fruits, vegetables and ...
Breaking Medicine News(10 mins):Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 2Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 3Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 4Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 5Health News:Gene Variant Seems to Guard Against Asthma, COPD 2Health News:Gene Variant Seems to Guard Against Asthma, COPD 3Health News:New from Episencial: All Natural, Actively Healthy Skin Care for Babies, Kids and Planet Features Eric Carle's "The Very Hungry Caterpillar" 2Health News:New from Episencial: All Natural, Actively Healthy Skin Care for Babies, Kids and Planet Features Eric Carle's "The Very Hungry Caterpillar" 3Health News:New from Episencial: All Natural, Actively Healthy Skin Care for Babies, Kids and Planet Features Eric Carle's "The Very Hungry Caterpillar" 4Health News:New from Episencial: All Natural, Actively Healthy Skin Care for Babies, Kids and Planet Features Eric Carle's "The Very Hungry Caterpillar" 5Health News:BioVeda Health and Wellness Center of Chanhassen, MN Announces Its Grand Opening 2Health News:BioVeda Health and Wellness Center of Chanhassen, MN Announces Its Grand Opening 3Health News:BioVeda Health and Wellness Center of Chanhassen, MN Announces Its Grand Opening 4Health News:BioVeda Health and Wellness Center of Chanhassen, MN Announces Its Grand Opening 5Health News:New Website Helps Grocers Comply With COOL Laws 2
... 4 Anna Kournikova has just returned from ... firsthand the combined effects of years of poverty, ... the local population. (Photo: http://www.newscom.com/cgi-bin/prnh/20090304/DC78519 ... experience it all," said Kournikova, following her visit. ...
... Bill Clinton, BMP Films and MTV Bring Academy Award-Winner Dustin ... To Life MTV and World Class Partners to Help Mobilize ... Calif., March 4 MTV, mtvU, LOGO and MTV Tr3s, ... of Pedro , a movie based on the remarkable ...
... group led Miguel ngel Fullana, researcher at the ... Legal Medicine, psychologist the Institute of Psychiatric Treatment ... at King,s College Institute of Psychiatry, London, has ... symptoms of obsessive-compulsive rituals in childhood with the ...
... SPRINGFIELD, Mass., March 4 MassMutual,s Retirement Services Division ... its TPA service team as a relationship manager for ... with plan reviews, investment change processing, product and service ... MassMutual,s platform. Mr. Carucci joined MassMutual on February 17 ...
... University of Texas Health Science Center at Houston and ... has received a five-year, $7 million Innovator Award from ... Program to develop a targeted new delivery system for ... could increase the efficiency of drug delivery by concentrating ...
... Marketing, (Pink Sheets: RPDM) has finalized an Agreement with ... the latest developments in neurotechnology for human computer interaction. ... responds to your emotions and thoughts to control objects ... technology has endless applications, such as operating wheel chairs, ...
Other Medicine News:Health News:PSI Brings Tennis Star Anna Kournikova to Haiti Bringing Hope and Assistance to Child Slaves 2Health News:PSI Brings Tennis Star Anna Kournikova to Haiti Bringing Hope and Assistance to Child Slaves 3Health News:World Television Premiere Event: The Film 'Pedro' Airs on MTV, MTV Tr3s, mtvU & LOGO on Wednesday, April 1 at 8:00 PM ET/PT 2Health News:World Television Premiere Event: The Film 'Pedro' Airs on MTV, MTV Tr3s, mtvU & LOGO on Wednesday, April 1 at 8:00 PM ET/PT 3Health News:World Television Premiere Event: The Film 'Pedro' Airs on MTV, MTV Tr3s, mtvU & LOGO on Wednesday, April 1 at 8:00 PM ET/PT 4Health News:World Television Premiere Event: The Film 'Pedro' Airs on MTV, MTV Tr3s, mtvU & LOGO on Wednesday, April 1 at 8:00 PM ET/PT 5Health News:World Television Premiere Event: The Film 'Pedro' Airs on MTV, MTV Tr3s, mtvU & LOGO on Wednesday, April 1 at 8:00 PM ET/PT 6Health News:Obsessive symptoms in childhood can multiply the probabilities of an obsessive compulsive disorder 2Health News:UT nanoscientist gets $7 million DoD Innovator Award for breast cancer research 2Health News:UT nanoscientist gets $7 million DoD Innovator Award for breast cancer research 3Health News:UT nanoscientist gets $7 million DoD Innovator Award for breast cancer research 4Health News:UT nanoscientist gets $7 million DoD Innovator Award for breast cancer research 5
... and Cronin, Inc. is ... Patient Footwear, Orthopedic Softgoods, ... Products. Our products are ... and available in the ...
DarcoGel™ Upper chamber is foam filled, conforms to calf; gel-filled lower chamber molds to the malleoli for a custom fit. Freeze the removable liner for cold therapy. One size. Fits left or ri...
Compression Ankle Support Four-way ankle compression support with reinforced triangular closed-heel design for comfort, mobility and longer wear. Reduces swelling and does not retain heat or moisture...
... combines the clinically proven Air-Stirrup Ankle ... addition, a comprehensive instruction booklet is ... provides information on treatment and rehabilitation ... management.,Each Air-Stirrup Ankle Brace features anatomically ...
Medicine Products: